Processa Pharmaceuticals Inc expected to post a loss of 10 cents a share - Earnings Preview

Processa Pharmaceuticals

03/11/2023 12:38

* Processa Pharmaceuticals Inc  PCSA.OQ   PCSA.O  is
expected
to show no change in quarterly revenue when it reports  results 
    * 
    * ​Refinitiv's mean analyst estimate for Processa
Pharmaceuticals
Inc is for a loss of 10 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The average consensus recommendation for
the pharmaceuticals
peer group is also "Buy".​
    * Wall Street's median 12-month price target for Processa
Pharmaceuticals Inc is $2.5​, above​ its last closing price
of $0.34. ​​​

This summary was machine generated November 3 at 12:38 GMT.  All
figures in US dollars  unless otherwise stated